SUMMARY
Global efforts regarding the COVID-19 pandemic have been focused on preventive activities, such as vaccination, since the disease is expected to become endemic. Adolescents were among the last population groups to be included in the vaccination program in Colombia, and adequate coverage has not yet been achieved in this group and in infants. It is important to understand their motivations to improve the willingness of this population to be vaccinated. A cross-sectional study was designed via an online survey in adolescents aged 14–19 years in Villavicencio Meta after validation of the survey and informed consent. The following options were provided for the question on vaccine disposition: willing, undecided, and unwilling. We described the disposition toward receiving COVID-19 vaccine using graphs and absolute and relative frequencies based on age group. A multinomial regression model was used to assess the relationship between our predictor variables and vaccine disposition in adolescents. In this study, 288 adolescents were surveyed. The risk variables for unwillingness to be vaccinated were being male (odds ratio [OR] 2.18, 95% confidence interval [CI] 0.8–5.7, p = 0.62), belonging to low social stratum (OR 2.29, 95% CI 0.9–5.88, p = 0.19), having a monthly family income of less than 1 million Colombian pesos (250 USD) (OR 2.01, 95% CI 0.8–5.16, p = 0.19), and having basic education (OR 2.59, 95% CI 0.33– 20.14, p = 0.18). Unproven myths and beliefs exert a profound influence on adolescents, which results in an unwillingness to be vaccinated. Hence, innovative public health strategies should be designed to improve the disposition to be vaccinated in this population group.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
This study is not a clinical trial
Funding Statement
This research project was funded by the Universidad Cooperativa de Colombia. Support for this research was provided through the payment of research hours to the principal investigator CGB, for a value of $6,046,000 (US$1,592), which corresponds to 4 hours of research per week, for 12 months. This institution had no influence on the design, objectives, execution and conclusions of the study.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The project was approved by the subcommittee on bioethics in research of the Cooperative University of Colombia, bioethics concept no. BIO254, march 1, 2022. The risk of participating in the survey was minimal according to Resolution No. 008430 of 1993, which establishes the scientific, technical, and administrative standards for health research in Colombia
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data are in the manuscript.
